Rockefeller Capital Management L.P. Sigilon Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

  • $34.7 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022
SELL
$0.48 - $0.86 $960 - $1,720
-2,000 Reduced 67.8%
950 $0
Q4 2021

Feb 14, 2022
BUY
$2.58 - $6.13 $2,451 - $5,823
950 Added 47.5%
2,950 $8,000
Q3 2021

Nov 12, 2021
BUY
$4.42 - $10.61 $8,840 - $21,220
2,000 New
2,000 $11,000

About Sigilon Therapeutics, Inc.

SGTX Quotes by TradingView
  • Ticker SGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,399,300
  • Description
  • Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...
More about SGTX
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email